CLINICAL TRIALS PROFILE FOR YUTOPAR
✉ Email this page to a colleague
All Clinical Trials for YUTOPAR
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03040752 ↗ | Comparative Study Between Nifedipine and Ritodrine as Maintenance Tocolytic Therapy in Preterm Labor | Completed | Cairo University | Phase 4 | 2015-01-01 | A randomized controlled double blinded study included 200 women with preterm contractions. After successful arrest of contractions women were randomized into 2 equal groups: GI women received nifedipine 20 mg tablets twice daily and GII women received Ritodrine 5 mg tablets every 6 hours. The primary outcome was gestational age at delivery and the secondary outcomes include episodes of recurrent preterm labor, mode of delivery, maternal side effects and neonatal outcome |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for YUTOPAR
Condition Name
Clinical Trial Locations for YUTOPAR
Clinical Trial Progress for YUTOPAR
Clinical Trial Phase
Clinical Trial Sponsors for YUTOPAR
Sponsor Name